Craig A. Barbarosh
CIK 1472457 · last filed 2026-06-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$4.55M
Companies
10
Total Filings
172
Lifetime Open-Market Net
-$923.6K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SBRA | Director | 158,242 | $22.26 | $3.52M | $31.8K | 70 | 2026-06-18 |
| EVH | Director | 95,031 | $3.74 | $355.4K | $17.6K | 8 | 2026-06-08 |
| LFCR | Director | 88,073 | $4.39 | $386.6K | $0 | 5 | 2024-07-10 |
| NEXTGEN HEALTHCARE, INC. (NXGN) Delisted | Director | 152,509 | $23.94 | $3.65M | -$998.1K | 14 | 2023-08-23 |
| LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Director | 20,863 | $8.76 | $182.8K | $0 | 7 | 2022-06-07 |
| ARATANA THERAPEUTICS, INC. (PETX) Delisted | Director | 0 | — | — | $0 | 3 | 2019-07-18 |
| Sabra Health Care REIT, Inc. (SBRAP) Delisted | Director | 58,059 | — | — | $0 | 13 | 2018-04-03 |
| BV | Director | 20,640 | $14.00 | $289.0K | $0 | 1 | 2017-10-02 |
| Sabra Health Care REIT, Inc. (SBRA.P) Delisted | Director | 46,881 | — | — | $25.0K | 32 | 2016-10-03 |
| Timber Pharmaceuticals, Inc. (BPMX) Delisted | Director | — | — | — | $0 | 3 | 2016-07-25 |
Recent Filings · Page 3 of 18
172 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-11-13 | — | Disp (D) | −67,269 | $0 | |
| 2023-09-05 | SBRA | Grant (A) | +1,101 | $0 | EDGAR |
| 2023-08-23 | NEXTGEN HEALTHCARE, INC. (NXGN) Delisted | Grant (A) | +10,086 | $165.0K | EDGAR |
| 2023-06-16 | SBRA | Grant (A) | +11,382 | $0 | EDGAR |
| 2023-06-12 | EVH | Grant (A) | +5,049 | $0 | EDGAR |
| 2023-06-05 | LFCR | Grant (A) | +18,182 | $0 | EDGAR |
| 2023-06-02 | SBRA | Grant (A) | +1,092 | $0 | EDGAR |
| 2023-06-01 | LFCR | Exer (M) | +9,474 | $0 | EDGAR |
| 2023-03-02 | SBRA | Grant (A) | +1,010 | $0 | EDGAR |
| 2023-02-02 | LFCR | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.